Omnicell Buys Mississippi-based nPharmics

Omnicell, Inc., a leading provider of medication and supply management solutions and adherence tools to healthcare systems and pharmacies, has completed the acquisition of InPharmics, a Mississippi-based technology and services company that provides advanced pharmacy informatics solutions to hospital pharmacies. The acquisition will expand the capabilities of Omnicell's Performance Center.

Health system pharmacies manage incredibly complicated clinical, distributive, and supply chain systems, and it is critical for pharmacy to understand and effectively manage the costs attributed to the medication use process while optimizing patient safety and regulatory compliance. InPharmics currently serves more than 150 hospitals with tools that analyze drug cost by patient diagnosis, thereby supporting pharmacy's clinical activities while helping to optimize supply chain performance and comply with drug pedigree regulations.

Omnicell Performance Center combines enterprise software solutions with ongoing expert services to proactively monitor pharmacy operations and deliver actionable insights for improved operational efficiency, regulatory compliance, and patient outcomes.

Financial details on the acquisition are not being disclosed at this time. Omnicell expects the transaction will be immaterial and does not expect it to impact Omnicell's previously communicated 2017 financial guidance.

InPharmics is the premier source for end-to-end medication use process cost analytics and Drug Supply Chain Security Act compliance systems specifically designed for acute care hospital pharmacies.